HYPR Stock Forecast: Hyperfine, Inc. Price Predictions for 2026-2027
The median 12-month analyst price target for Hyperfine, Inc. is $2. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 42 of 100 as at 21 Nov 2026 — in the lower half.
One number for the whole business
Consensus tells you what everyone already believes. The model scores Hyperfine, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Growth (98): Sales and profits are climbing, and climbing faster than before.
Issuance (8): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
HYPR stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on HYPR, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 18 Nov 2026 | B. Riley Securities | Reiterates | Buy | $1.60 → $1.40 |
| 27 Oct 2026 | Lucid Capital Markets | Initiates | Buy | $2.00 |
| 22 Sept 2026 | BTIG | Reiterates | Buy | $2.00 |
| 14 Sept 2026 | BTIG | Reiterates | Buy | $2.00 |
| 10 Aug 2026 | B. Riley Securities | Reiterates | Buy | $2.00 → $1.60 |
| 29 Apr 2026 | BTIG | Initiates | Buy | $2.00 |
| 19 Mar 2026 | Lake Street | Maintains | Buy | — |
| 15 Aug 2025 | Wells Fargo | Maintains | Equal-Weight | — |
| 14 Aug 2025 | Lake Street | Maintains | Buy | — |
| 15 May 2025 | B. Riley Securities | Maintains | Buy | — |
| 14 May 2025 | Wells Fargo | Maintains | Equal-Weight | — |
| 24 Mar 2025 | Lake Street | Initiates | Buy | — |
| 20 Mar 2025 | B. Riley Securities | Maintains | Buy | — |
| 18 Mar 2025 | Wells Fargo | Maintains | Equal-Weight | — |
| 22 Mar 2024 | Wells Fargo | Maintains | Equal-Weight | — |
| 30 Nov 2023 | Jefferies | Initiates | Hold | — |
| 15 Aug 2023 | B. Riley Securities | Maintains | Buy | — |
| 22 Mar 2023 | B. Riley Securities | Maintains | Buy | — |
| 4 Oct 2022 | B. Riley Securities | Initiates | Buy | — |
| 11 Aug 2022 | Wells Fargo | Downgrade | Equal-Weight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for HYPR.
This page is one stock. Monday covers all of them.
HYPR appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
HYPR vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, Hyperfine, Inc. returned −47.1% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
HYPR analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 3.0×
- Price / book
- 1.8×
- EV / EBITDA
- —
Cheaper than 36% of US stocks
Cheaper than 47% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- 50.7%
- Operating margin
- —
- Net margin
- —
Higher than 63% of US stocks
- Return on equity
- −101.7%
- Return on assets
- −40.2%
- Dividend yield
- —
Higher than 13% of US stocks
Higher than 10% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Hyperfine, Inc. has a market value of $58.0M and an enterprise value of $34.3M.
Revenue in the twelve months to 30 June 2026: $16.5M. The latest quarter grew 44.8% year on year.
Net income over the same four quarters: −$34.9M, a −210.8% net margin.
Diluted earnings per share, trailing twelve months: −$0.38.
Free cash flow in the twelve months to 30 June 2026: −$27.5M.
Hyperfine, Inc. employs 102 people — $162K of revenue per employee.
Data provided by Twelve Data
HYPR and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at HYPR’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own Hyperfine, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about HYPR
What is the HYPR stock price forecast for 2026-2027?
The median 12-month analyst price target for Hyperfine, Inc. is $2, with estimates ranging from $1.4 to $2.5. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is HYPR stock a buy right now?
Of the 4 analysts covering Hyperfine, Inc., 4 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Hyperfine, Inc. 42 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank HYPR?
As at 21 Nov 2026, Hyperfine, Inc. ranks 42 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Growth (98 of 100).
Will HYPR stock go up?
No one can know that. What the data says: the median 12-month target from 4 analysts is $2, and Ticker Nerd's factor model ranks Hyperfine, Inc. 42 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the HYPR stock forecast for 2030?
No analyst covering Hyperfine, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HYPR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $1.4 to $2.5 over the next 12 months.
How has HYPR stock performed over the past year?
Hyperfine, Inc. returned -47.1% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Hyperfine, Inc. do?
Hyperfine, Inc. Class A Common Stock represents the equity of Hyperfine, Inc., a health technology and medical device company focused on portable magnetic resonance imaging. The company develops and commercializes the Swoop portable MR imaging system, which is designed to support brain imaging and clinical monitoring in settings where traditional MRI systems are less practical.
About Hyperfine, Inc.
Hyperfine, Inc. Class A Common Stock represents the equity of Hyperfine, Inc., a health technology and medical device company focused on portable magnetic resonance imaging. The company develops and commercializes the Swoop portable MR imaging system, which is designed to support brain imaging and clinical monitoring in settings where traditional MRI systems are less practical. Hyperfine also provides related support, maintenance, and technical services tied to its imaging products. Its offerings serve hospitals, intensive care units, stroke centers, and other medical facilities that use portable neuroimaging to help broaden access to diagnostic imaging. Based in Guilford, Connecticut, Hyperfine operates in the medical specialties segment of the health technology market, where it combines imaging hardware, software, and service capabilities around ultra-low-field MRI applications.
CEO Ms. Maria Degois-Sainz · 102 employees · United States · https://www.hyperfinemri.com